查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1373934

糖尿病治療市場，按治療類型、疾病、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Diabetes Therapeutics Market, By Therapy Type, By Diseases, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 308 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年糖尿病治療市場規模為 652.001 億美元，2023年至2030年CAGR為 5.9%。

此外，持續監測、病患教育和積極參與是糖尿病治療不可或缺的面向。這些元素在實現血糖控制、降低併發症風險以及促進糖尿病患者的長期健康和福祉方面發揮關鍵作用。

糖尿病治療市場-市場動態

全球糖尿病盛行率上升推動市場需求

1 型和第2 型糖尿病的發生率不斷上升，通常與久坐的生活方式，不健康的飲食習慣和肥胖等因素有關，導致對有效治療的需求不斷增加。糖尿病診斷和相關併發症數量的不斷增加給全球醫療保健系統帶來了巨大壓力。為此，製藥公司和研究人員被迫開發新的治療方法，包括改良的胰島素配方、創新的口服藥物以及連續血糖監測和人工胰臟系統等尖端技術。解決糖尿病流行已成為醫療保健的首要任務。

糖尿病治療市場 - 關鍵見解

根據研究分析師提供的分析，預計2023年至2030年的預測期內，全球糖尿病治療市場的年成長率約為 5.9%。

糖尿病治療產業有望大幅成長，這主要歸因於全球糖尿病盛行率的增加。

在治療類型細分方面，2022年口服降血糖藥物成為主導類別。

在疾病細分方面，妊娠糖尿病已成為2022年的主要治療類型。

糖尿病治療市場-細分分析：

全球糖尿病治療市場圍繞著關鍵參數構建，包括治療類型、疾病、最終用戶和地區。

在治療類型類別中，市場分為三個主要部分：口服抗糖尿病藥物、注射抗糖尿病藥物和其他。值得注意的是，口服抗糖尿病藥物領域在市場中佔據主導地位。糖尿病治療領域對口服降血糖藥物有著巨大的需求。這些藥物通常以藥丸或片劑的形式提供，在幫助第2 型糖尿病患者有效控制血糖值方面發揮著非常重要的作用。它們是口服治療的基石，有助於控制血糖和減少併發症。

糖尿病治療市場 - 地理洞察

糖尿病治療市場遍佈各個地區，包括北美、拉丁美洲、歐洲、亞太地區、中東和非洲，每個地區又根據從事商業活動的各國進一步細分。

值得注意的是，由於多種因素的綜合作用，亞太地區對糖尿病藥物的需求量很大。首先，該地區的糖尿病盛行率激增，這主要是由城市化、久坐的生活方式和飲食習慣的轉變所推動的。這些因素共同導致亞太地區對有效糖尿病治療的需求不斷成長。

糖尿病治療市場-競爭格局：

糖尿病藥物市場呈現動態和競爭格局，主要製藥巨頭和新興生技公司處於領先地位。胰島素領域的主要競爭對手，包括Novo Nordisk、Sanofi和Eli Lilly，透過開發和提供廣泛的胰島素療法、注射GLP-1 受體激動劑和口服糖尿病藥物發揮著非常重要的作用。

此外，Dexcom 和 Medtronic 等設備製造商透過提供連續血糖監測系統和胰島素輸送設備，向市場推出創新解決方案並增強糖尿病患者的治療選擇，為這種競爭環境做出了貢獻。

目錄

第1章 糖尿病治療市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依疾病分類的糖尿病治療市場摘錄
    • 依治療類型分類的糖尿病治療市場摘錄
    • 依最終使用者的糖尿病治療市場摘錄
    • 依國家分類的糖尿病治療市場摘錄
    • 依地區分類的糖尿病治療市場摘錄
  • 競爭洞察

第3章 糖尿病治療主要市場趨勢

  • 糖尿病治療市場促進因素
    • 市場促進因素的影響分析
  • 糖尿病治療市場限制
    • 市場限制影響分析
  • 糖尿病治療市場機會
  • 糖尿病治療市場未來趨勢

第4章 糖尿病治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 糖尿病治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 糖尿病治療市場格局

  • 2022年糖尿病治療市佔率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 糖尿病治療市場 - 依疾病分類

  • 概述
    • 依疾病分類的細分市場佔有率分析
    • 1 型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病

第8章 糖尿病治療市場 - 依治療類型

  • 概述
    • 依治療類型分類的細分市場佔有率分析
    • 口服抗糖尿病藥
    • 注射型抗糖尿病藥
    • 其他

第9章 糖尿病治療市場 - 依最終用戶

  • 概述
    • 依最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 居家護理
    • 其他

第10章 糖尿病治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美糖尿病治療主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模與預測（依疾病）
    • 北美市場規模和預測（依治療類型）
    • 北美市場規模和預測（依最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲糖尿病治療藥物主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依疾病）
    • 歐洲市場規模和預測（依治療類型）
    • 歐洲市場規模和預測（依最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區糖尿病治療主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依疾病）
    • 亞太地區市場規模與預測（依治療類型）
    • 亞太地區市場規模和預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲糖尿病治療主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依疾病）
    • 拉丁美洲市場規模與預測（依治療類型）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲糖尿病治療藥物主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依疾病）
    • 中東和非洲市場規模和預測（依治療類型）
    • 中東和非洲市場規模和預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章 主要供應商分析 - 糖尿病治療產業

  • 競爭儀表板
  • 公司簡介
    • Astrazeneca PLC
    • Boehringer Ingelheim GmbH
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Novartis AG
    • Novo Nordisk
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Johnson and Johnson Md&D
    • Merck and Co. Inc.

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1798

REPORT HIGHLIGHT

Diabetes Therapeutics Market size was valued at USD 65,200.1 Million in 2022, expanding at a CAGR of 5.9 % from 2023 to 2030.

Diabetes therapies encompass a diverse range of medical strategies and interventions devised for the management of diabetes mellitus, a chronic metabolic disorder characterized by elevated blood sugar levels. These therapeutic approaches are aimed at aiding individuals with diabetes in regulating their blood glucose levels, preventing complications, and ultimately improving their overall quality of life. The spectrum of diabetes treatment options includes dietary and lifestyle modifications, as well as oral medications, injectable insulin, and various pharmacological interventions.

Moreover, continuous monitoring, patient education, and active involvement are integral aspects of diabetes therapies. These elements play a pivotal role in achieving glycemic control, reducing the risk of complications, and fostering the long-term health and well-being of individuals living with diabetes.

Diabetes Therapeutics Market- Market Dynamics

Global rise in diabetes prevalence propels market demand

The escalating incidence of both type 1 and type 2 diabetes, often associated with factors such as sedentary lifestyles, unhealthy dietary habits, and obesity, has led to an increasing demand for effective therapies. The mounting number of diabetes diagnoses and related complications is placing substantial pressure on healthcare systems worldwide. In response, pharmaceutical companies and researchers are driven to develop novel treatments, including improved insulin formulations, innovative oral medications, and cutting-edge technologies such as continuous glucose monitoring and artificial pancreas systems. Addressing the diabetes epidemic has emerged as a paramount healthcare priority.

Diabetes Therapeutics Market- Key Insights

Based on the analysis provided by our research analyst, the global market for Diabetes Therapeutics is anticipated to experience an annual growth rate of approximately 5.9% over the forecast period spanning from 2023 to 2030.

The Diabetes Therapeutics industry is poised for substantial growth, largely attributed to the global increase in the prevalence of diabetes.

In terms of Therapy Type segmentation, the year 2022 witnessed Oral Antidiabetics as the dominant category.

Regarding Diseases segmentation, Gestational diabetes emerged as the leading Therapy Type in 2022.

Diabetes Therapeutics Market- Segmentation Analysis:

The Global Diabetes Therapeutics Market is structured around key parameters, including Therapy Type, Diseases, End User, and Region.

Within the Therapy Type category, the market is categorized into three primary segments: Oral Antidiabetics, Injectable Antidiabetics, and Others. Notably, the Oral Antidiabetics sector assumes a dominant position within the market. There is significant demand for oral antidiabetics in the field of diabetes therapeutics. These medications, often available in the form of pills or tablets, play a vital role in helping individuals with type 2 diabetes manage their blood sugar levels effectively. They are a cornerstone of oral treatment, contributing to glucose control and the reduction of complications.

Diabetes Therapeutics Market- Geographical Insights

The market for diabetes therapeutics spans across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further segmented by individual countries engaged in business activities.

Notably, there is a substantial demand for diabetes medications in the Asia-Pacific region, attributed to several converging factors. Firstly, the region is witnessing a surge in diabetes prevalence, primarily fueled by urbanization, sedentary lifestyles, and dietary shifts. These factors collectively contribute to the growing need for effective diabetes treatments in the Asia-Pacific region.

Diabetes Therapeutics Market- Competitive Landscape:

The diabetes medications market features a dynamic and competitive landscape, with major pharmaceutical giants and emerging biotech companies at the forefront. Prominent competitors in the insulin sector, including Novo Nordisk, Sanofi, and Eli Lilly, play a crucial role by developing and offering a wide range of insulin therapies, injectable GLP-1 receptor agonists, and oral diabetes medications.

Furthermore, device manufacturers like Dexcom and Medtronic contribute to this competitive environment by providing continuous glucose monitoring systems and insulin delivery devices, introducing innovative solutions to the market and enhancing the treatment options available to individuals living with diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIABETES THERAPEUTICS MARKET KEY PLAYERS

  • Astrazeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Novartis AG
  • Novo Nordisk
  • Sanofi SA
  • Takeda Pharmaceutical Company Limited
  • Johnson and Johnson Md&D
  • Merck and Co. Inc.

GLOBAL DIABETES THERAPEUTICS MARKET, BY THERAPY TYPE

  • Oral Antidiabetics
  • Injectable Antidiabetics
  • Others

GLOBAL DIABETES THERAPEUTICS MARKET, BY DISEASES

  • Type 1 diabetes
  • Type 2 diabetes
  • Gestational diabetes

GLOBAL DIABETES THERAPEUTICS MARKET, BY END USER

  • Hospitals and Clinics
  • Homecare
  • others

GLOBAL DIABETES THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Diabetes Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Diabetes Therapeutics Market Snippet by Diseases
    • 2.1.2. Diabetes Therapeutics Market Snippet by Therapy Type
    • 2.1.3. Diabetes Therapeutics Market Snippet by End User
    • 2.1.4. Diabetes Therapeutics Market Snippet by Country
    • 2.1.5. Diabetes Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Diabetes Therapeutics Key Market Trends

  • 3.1. Diabetes Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Diabetes Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Diabetes Therapeutics Market Opportunities
  • 3.4. Diabetes Therapeutics Market Future Trends

4. Diabetes Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Diabetes Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Diabetes Therapeutics Market Landscape

  • 6.1. Diabetes Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Diabetes Therapeutics Market - By Diseases

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
    • 7.1.2. Type 1 diabetes
    • 7.1.3. Type 2 diabetes
    • 7.1.4. Gestational diabetes

8. Diabetes Therapeutics Market - By Therapy Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
    • 8.1.2. Oral Antidiabetics
    • 8.1.3. Injectable Antidiabetics
    • 8.1.4. Others

9. Diabetes Therapeutics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Homecare
    • 9.1.4. others

10. Diabetes Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Diabetes Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Diabetes Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Diabetes Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Diabetes Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Diabetes Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Diabetes Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Astrazeneca PLC
    • 11.2.2. Boehringer Ingelheim GmbH
    • 11.2.3. Eli Lilly and Company
    • 11.2.4. GlaxoSmithKline PLC
    • 11.2.5. Novartis AG
    • 11.2.6. Novo Nordisk
    • 11.2.7. Sanofi SA
    • 11.2.8. Takeda Pharmaceutical Company Limited
    • 11.2.9. Johnson and Johnson Md&D
    • 11.2.10. Merck and Co. Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Therapy Types
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diabetes Therapeutics Market: Diseases Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Diabetes Therapeutics Market, by Diseases 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: Therapy Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global Diabetes Therapeutics Market, by Therapy Type 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Diabetes Therapeutics Market, by End User 2018-2030 (USD Million)
  • TABLE Diabetes Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diabetes Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE North America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Europe Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Latin America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)